Trial Profile
A Study of Duloxetine (LY248686) in Participants With Diabetic Peripheral Neuropathic Pain
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Oct 2018
Price :
$35
*
At a glance
- Drugs Duloxetine (Primary) ; Pregabalin
- Indications Diabetic neuropathies; Neuropathic pain
- Focus Therapeutic Use
- Sponsors Eli Lilly and Company; Shionogi
- 19 Oct 2018 Status changed from recruiting to completed.
- 14 Jun 2016 New trial record